Inventor · disambiguated record
Alexander Oksche
Also filed as: OKSCHE ALEXANDER
11 granted patents·10 pending applications·17 citations·filing 2003–2023
86Inventor score
Files withEURO CELTIQUE SA9HARM REDUCTION THERAPEUTICS INC3PURDUE PHARMA LP3RHODES PHARMACEUTICALS LP3OKSCHE ALEXANDER2
Top patents by PatentIndex Score
21 records- 0192US11020343B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2019·Granted Jun 1, 2021·7 cites·13 claims
- 0290US11806428B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·2 cites·35 claims
- 0384US12458591B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2023·Granted Nov 4, 2025·0 cites·17 claims
- 0480US9370512B2Buprenorphine-wafer for drug substitution therapyPURDUE PHARMA LP·Filed 2015·Granted Jun 21, 2016·2 cites·24 claims
- 0578US9101625B2Buprenorphine-wafer for drug substitution therapyOKSCHE ALEXANDER·Filed 2007·Granted Aug 11, 2015·3 cites·14 claims
- 0670US7863432B2Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor proteinFORSCHUNGSVERBUND BERLIN EV·Filed 2003·Granted Jan 4, 2011·3 cites·8 claims
- 0765US2019216797A1Buprenorphine-wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2018·Application pending·0 cites
- 0865US2015025102A1Buprenorphine-Wafer for Drug Substitution TherapyEURO CELTIQUE SA·Filed 2014·Application pending·0 cites
- 0964US10898479B2Dihydroetorphine for the provision of pain relief and anaesthesiaEURO CELTIQUE SA·Filed 2014·Granted Jan 26, 2021·0 cites·32 claims
- 1063US2018008595A1Buprenorphine wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2017·Application pending·0 cites
- 1162US2017157062A1Buprenorphine-Wafer for Drug Substitution TherapyPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 1261US9861628B2Buprenorphine-wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2016·Granted Jan 9, 2018·0 cites·15 claims
- 1361US9763931B2Buprenorphine-wafer for drug substitution therapyPURDUE PHARMA LP·Filed 2016·Granted Sep 19, 2017·0 cites·24 claims
- 1460US2017304192A1Intranasal pharmaceutical dosage forms comprising naloxoneEURO CELTIQUE SA·Filed 2017·Application pending·0 cites
- 1559US2017231904A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2017·Application pending·0 cites
- 1657US2015018379A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2012·Application pending·0 cites
- 1757US2021085673A1Dihydroetorphine for the provision of pain relief and anaesthesiaEURO CELTIQUE SA·Filed 2020·Application pending·0 cites
- 1854US2015126540A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2015·Application pending·0 cites
- 1950US2014066475A1Method For Treating PruritusEURO CELTIQUE SA·Filed 2013·Application pending·0 cites
- 2043US9782359B2Opioid composition for treating skin lesionsOKSCHE ALEXANDER·Filed 2009·Granted Oct 10, 2017·0 cites·33 claims
- 2142US10071089B2Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocationEURO CELTIQUE SA·Filed 2014·Granted Sep 11, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Alexander Oksche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →